Schedule 13G ownership disclosure

Ginkgo Bioworks Holdings Inc

Common Stock · CUSIP: 37611X209

Event date: 2025-06-30

Filing-level shares
2,381,115
Percent of class
5.13%
  • The Vanguard Group

    Shares: 2,381,115 · Class: 5.13%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000894
Form type
SCHEDULE 13G
Filer
Ginkgo Bioworks Holdings, Inc.
CIK
CIK 1830214
Filed
Jul 29, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub